Pharming B.V.
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Industrial and Commercial Machinery and Equipment, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Pharming B.V.
Live alerts from global media, monitored by Business Radar
2025-05-08 (deaandeelhouder.nl)
Pharming increases Outlook: Strong quarter of Ruconest
A strong quarter in Ruconest, with a 40% growth compared to a year ago, is a reason for Pharming to increase the Outlook for this year by 10 million dollars. Strong quarter Ruconest cost savings head office Outlook increased the new CEO Fabrice Chouraqui, just in function, is very pleased with the increased demand for Ruconest
Read more
2025-03-13 (beurs.nl)
Operational profit Pharming is increasing
Pharming saw the operational profit rise sharply in the fourth quarter, and counts slightly less strong growth before 2025, after the turnover goal was surpassed last year. The Leiden biotech company announced this on Thursday morning.
Read more